References
- Bielinski SJ, St Sauver JL, Olson JE, et al. Cohort profile: the right drug, right dose, right time: using genomic data to individualize treatment protocol (RIGHT Protocol). Int J Epidemiol. 2020;49(1):23–24k. doi:10.1093/ije/dyz123
- Caraballo PJ, Bielinski SJ, St Sauver JL, Weinshilboum RM. Electronic medical record-integrated pharmacogenomics and related clinical decision support concepts. Clin Pharmacol Ther. 2017;102(2):254–264. doi:10.1002/cpt.707
- Takahashi PY, Ryu E, Bielinski SJ, et al. No association between pharmacogenomics variants and hospital and emergency department utilization: a Mayo Clinic Biobank retrospective study. Pharmgenomics Pers Med. 2021;14:229–237. doi:10.2147/PGPM.S281645
- Takahashi PY, Ryu E, Pathak J, et al. Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6. Pharmgenomics Pers Med. 2017;10:39–47. doi:10.2147/PGPM.S114211